Data missing for daytime symptoms on 1 subject, nocturnal symptoms in 2 subjects, SABA use in 15 subjects, functional status on 12 subjects.†Only 2 subjects used omalizumab: 1 in Group 2 and 1 in Grou
The file 'cases.zip' contains data for 15 case studies used in the experiments discussed in the paper, see 'readme' file for the description how to use the data.The file 'python scripts.zip' is the co
Supplemental references for Table 1 for the systematic review titled "Safety and Efficacy of Spironolactone in Pediatric Dermatology: a Scoping Review"
